The Politics of Scientific Research: An Interview With NIH Director Zerhouni
This article was originally published in The Pink Sheet Daily
Executive Summary
Timing of Zerhouni’s resignation means federal research policy issues – from stem cells to industry collaborations – will get attention as part of the new administration’s transition efforts.
You may also be interested in...
NIH Director Nominee Collins May Push Translational Medicine Into Spotlight
Francis Collins' intellectual agility and experience working on huge initiatives with a lot of moving parts - the human genome project comes to mind - will serve him well as the National Institutes of Health's director
NIH Director Nominee Collins May Push Translational Medicine Into Spotlight
Francis Collins' intellectual agility and experience working on huge initiatives with a lot of moving parts - the human genome project comes to mind - will serve him well as the National Institutes of Health's director
NIH Director Nominee Francis Collins May Push Translational Medicine Further Into The Agency Spotlight
The physician-geneticist and former genome institute director likely will focus on personalized medicine during his tenure at the agency.